Cargando…

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition

Aristolochic acid nephropathy (AAN) is a progressive tubulointerstitial nephritis caused by the intake of aristolochic acids (AA) contained in Chinese herbal remedies or contaminated food. AAN is characterized by tubular atrophy and interstitial fibrosis, characterizing advanced kidney disease. It i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baudoux, Thomas, Jadot, Inès, Declèves, Anne-Emilie, Antoine, Marie-Hélène, Colet, Jean-Marie, Botton, Olivia, De Prez, Eric, Pozdzik, Agnieszka, Husson, Cécile, Caron, Nathalie, Nortier, Joëlle L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115860/ https://www.ncbi.nlm.nih.gov/pubmed/35602498 http://dx.doi.org/10.3389/fmed.2022.822870

Ejemplares similares

CD4(+) and CD8(+) T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy
por: Baudoux, Thomas, et al.
Publicado: (2018)

An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature
por: Jadot, Inès, et al.
Publicado: (2017)

Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy
por: Jadot, Inès, et al.
Publicado: (2017)

Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells
por: Antoine, Marie-Hélène, et al.
Publicado: (2022)

Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats
por: Pozdzik, Agnieszka A., et al.
Publicado: (2016)

The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
por: Sborchia, Mateja, et al.
Publicado: (2019)

Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts
por: Lablad, Yahya, et al.
Publicado: (2023)

Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers
por: Bunel, Valérian, et al.
Publicado: (2017)

Nephroprotective Effects of Two Ganoderma Species Methanolic Extracts in an In Vitro Model of Cisplatin Induced Tubulotoxicity
por: Sinaeve, Sébastien, et al.
Publicado: (2022)

Sex differences in obesity-induced renal lipid accumulation revealed by lipidomics: a role of adiponectin/AMPK axis
por: Juszczak, Florian, et al.
Publicado: (2023)

Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition
por: Kuang, Qing, et al.
Publicado: (2021)

Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Circulating (CD3(−)CD19(+)CD20(−)IgD(−)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
por: Pozdzik, Agnieszka, et al.
Publicado: (2016)

Meta-analysis of AKI to CKD transition in perioperative patients
por: M. Abdala, Pedro, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
por: Premužić, Vedran, et al.
Publicado: (2018)

Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
por: Yi, Joo-Hark, et al.
Publicado: (2018)

«Suspects» in Etiology of Endemic Nephropathy: Aristolochic Acid versus Mycotoxins
por: Pepeljnjak, Stjepan, et al.
Publicado: (2010)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy
por: Tseng, Chiao-Shih, et al.
Publicado: (2011)

Smad7 protects against chronic aristolochic acid nephropathy in mice
por: Dai, Xiao-Yu, et al.
Publicado: (2015)

Protective Effects of Melatonin Against Aristolochic Acid-Induced Nephropathy in Mice
por: Kim, Jung-Yeon, et al.
Publicado: (2019)

Growing risk of aristolochic acid nephropathy in the era of COVID-19 – Correspondence
por: Das, Tuyelee, et al.
Publicado: (2022)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

Influence of Nutritional Intake of Carbohydrates on Mitochondrial Structure, Dynamics, and Functions during Adipogenesis
por: Delcourt, Manon, et al.
Publicado: (2020)

Investigation of Mitochondrial Adaptations to Modulation of Carbohydrate Supply during Adipogenesis of 3T3-L1 Cells by Targeted (1)H-NMR Spectroscopy
por: Delcourt, Manon, et al.
Publicado: (2021)

Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice
por: Dai, Xiao Y., et al.
Publicado: (2016)

Blockade of the mTOR signaling pathway with rapamycin ameliorates aristolochic acid nephropathy
por: Wu, Minmin, et al.
Publicado: (2020)

Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
por: Ishii, Takeo, et al.
Publicado: (2021)

Delayed Exercise Training Improves Obesity-Induced Chronic Kidney Disease by Activating AMPK Pathway in High-Fat Diet-Fed Mice
por: Juszczak, Florian, et al.
Publicado: (2020)

The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD
por: Kim, Dong-Hyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a2uudohp8sh82j2oepn5k7iud3